Galenica AG (GALE)
Galleinphi will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.00 - $6.00
Shares Offered
3,000,000
Deal Size
$15.00M

Company Description

Galenica AG operates as a healthcare service provider in Switzerland and internationally.

It operates in two segments, Products & Care, and Logistics & IT. The Products & Care segment operates pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice.

This segment also offers medication for treatment of patients at home; and develops, markets, and sells healthcare services and products through various distribution channels.

The Logistics & IT segment provides various specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies.

This segment also offers master data system for the healthcare market; develops management solutions for the healthcare market; provides group internal IT services; distributes the former Viatris OTC products; and publishes printed and electronic technical information on pharmaceutical products, as well as offers complete management solutions for pharmacies.

The company was founded in 1927 and is headquartered in Bern, Switzerland.

Galenica AG
Galleinphi logo
Country Switzerland
Founded 1927
Industry Other
Employees 7,971
CEO Marc Werner

Contact Details

Address:
Untermattweg 8
Bern, Zhejiang Province 3027
Switzerland
Phone 41 58 852 81 11
Website galenica.com

Stock Details

Ticker Symbol GALE
Exchange NASDAQ
Fiscal Year July - June
Reporting Currency CHF
CIK Code 0002004906
ISIN Number US81642T1007
SIC Code 5122

Key Executives

Name Position
Jiayang Zhu Chief Executive Officer, Executive Director
Zhongxiang Zhao Chief Financial Officer, Executive Director
Wen Jia Executive Director, Chairwoman of the Board

Latest SEC Filings

Date Type Title
May 13, 2024 F-1 Registration statement for certain foreign private issuers
Mar 18, 2024 DRS/A [Amend] [Cover] Draft Registration Statement
Feb 9, 2024 DRS/A [Amend] [Cover] Draft Registration Statement
Dec 21, 2023 DRS [Cover] Draft Registration Statement